Amgen Inc (AMGN · NASDAQ)

AMGN · MARKET VIEW

Market view · as of Aug 3, 2026

Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
93.8%
-2.0% vs 52w high · +2.9% 1mo

Price (last ~year)

Amgen Inc. (AMGN) is trading at $385.16, reflecting a 17.8% gain over the past three months and positioning the stock at 93.8% of its 52-week range. The firm generated $37.22B in TTM revenue with 5.8% year-over-year growth and has exceeded analyst earnings estimates in each of the last four quarters. As of March 31, 2026, the company reported an operating margin of 33.8% and a Debt/EBITDA ratio of 3.4x, with $57.32B in total debt against $12.04B in cash.

Valuation

Market cap
$207.87B
P/E
26.8
PEG
2.114
P/B
22.62
P/S
5.58
EV/EBITDA
15.18
Beta
0.403
Analyst target
$357.03

Quality & returns

Gross margin
71.4%
Operating margin
33.8%
Profit margin
21.0%
ROE
101.3%
ROA
8.3%

Price movement

Last
$385.16
1-month
+2.9%
3-month
+17.8%
RSI (14)
69
vs SMA200
+13.1%
52-wk position
93.8% -2.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$8.62B$2.67B$1.82B$3.86B
2025-12-31$9.90B$3.94B$1.33B$3.30B
2025-09-30$9.56B$2.53B$3.22B$5.91B
2025-06-30$9.17B$2.64B$1.43B$3.62B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots